Skip to main content
Fig. 3 | BMC Veterinary Research

Fig. 3

From: Effect of intralesional platelet-rich plasma (PRP) treatment on clinical and ultrasonographic parameters in equine naturally occurring superficial digital flexor tendinopathies – a randomized prospective controlled clinical trial

Fig. 3

Ultrasound tissue characterization: Proportion of echo-types I-IV. Proportion of echo types a I, b II, c III and d IV for PRP and saline treated SDFTs; PRP-group: solid lines; Control group: dotted lines; Mean ± SE; Values labelled with asterisk (*) differ significantly (p < 0.05) between groups. Global tests: echo type I: PRPG p = 0.099, CG p = 0.004; echo type II: PRPG p = 0.204, CG p = 0.057; echo type III: PRPG p < 0.001, CG p = 0.002; echo type IV: PRPG p < 0.001, CG p = 0.940; Different letters (PRP normal and control italic) indicate significant differences (p < 0.05) within groups; PRPG = PRP-group: n = 10 limbs, SDFTs treated intralesionally with PRP; CG = control group: n = 10 limbs, SDFTs treated intralesionally with saline; PRP = platelet-rich plasma; SDFT = superficial digital flexor tendon; w = weeks

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us